TruthArchive.ai - Tweets Saved By @McCulloughFund

@McCulloughFund - McCullough Foundation

Beat Airborne Viruses: Why Nasal Sprays and Gargles Work Respiratory viruses replicate in the nasal passages for several days before symptoms appear. Using nasal sprays and gargles twice daily can disrupt viral replication early, lowering viral load before it reaches the throat or lungs. This approach has shown consistent benefit across multiple respiratory illnesses and is not limited to COVID. Support independent research: http://mcculloughfnd.org 🔗 Full episode: https://youtu.be/NQ1NTSpfhwk?si=_1eURF6E6SvquEZ8 Credit: Get Better Faster Podcast — @thegbfpodcast #MedicalFreedom

McCullough Foundation Peter A. McCullough, MD, MPH Fighting for medical freedom through scientific data and analysis. mcculloughfnd.org

@McCulloughFund - McCullough Foundation

🔥“COVID-19 Vaccines Didn’t Save Lives” — Dr. McCullough Dropped the Hammer in the U.S. Senate 💥“You’ve asked for evidence. Three papers by Nathaniel Mead — nearly 1,000 references — conclude the risks of COVID-19 vaccination FAR outweigh any theoretical benefits.” @P_McCulloughMD @NathanMeadPhD @SenRonJohnson #MFPolicy

@McCulloughFund - McCullough Foundation

The Vatican's COVID-19 Vaccine Coin Last year, Vatican City issued a 20 Euro silver coin. As the Numista catalogue describes it: "The coin depicts a doctor, a nurse and a young person who is ready to receive the vaccine. The Holy Father has repeatedly stressed the importance of vaccination, recalling that healthcare is “a moral obligation”, and it is important to “continue efforts to immunize even the poorest peoples." @P_McCulloughMD #MFEducation

@McCulloughFund - McCullough Foundation

The Reputations of Researchers at the Erasmus Institute & National Poultry Research Center It wasn't until "someone finally convinced me to do something really, really stupid," Ron Fouchier said, that they observed the deadly H5N1 become a viable aerosol virus. In the derided experiment, they let the virus itself evolve to gain that killer capacity. To do that, they put the mutated virus in the nose of one ferret; after that ferret got sick, they put infected material from the first ferret into the nose of a second. After repeating this 10 times, H5N1 became as easily transmissible as the seasonal flu. Many scientists agreed with Ron Fouchier that he had done “something really, really stupid.” In the United States, Dr. Thomas Inglesby—a bioterrorism expert and director of the Center for Biosecurity of the University of Pittsburgh Medical Center—remarked: "It's just a bad idea for scientists to turn a lethal virus into a lethal and highly contagious virus. And it's a second bad idea for them to publish how they did it so others can copy it." Another prominent American critic was microbiologist Richard Ebright of Rutgers University in Piscataway, New Jersey, who asserted: “This work should never have been done.” Read full article by @johnsearsleake on Courageous Discourse: https://bit.ly/4fJ0zIz @R_H_Ebright #MFScholar

Bitly | Page Not Found | 404 bit.ly

@McCulloughFund - McCullough Foundation

BREAKING - Our new study presents strong evidence that the current HPAI H5N1 "Bird Flu" Clade 2.3.4.4b outbreak is a result of laboratory leaks from the USDA Southeast Poultry Research Laboratory (SEPRL) in Athens, Georgia and the Erasmus Medical Center in Rotterdam, the Netherlands. Genetic evidence and historical context suggest that laboratory activities, including serial passage and gain-of-function research, could have contributed to the emergence of H5N1 clade 2.3.4.4b. A moratorium on gain-of-function research including serial passage of H5N1 is indicated to prevent a man-made influenza pandemic affecting animals and humans. https://www.preprints.org/manuscript/202406.0060/v1 #MFScholar

Proximal Origin of Epidemic Highly Pathogenic Avian Influenza H5N1 Clade 2.3.4.4b and Spread by Migratory Waterfowl We investigate the possible laboratory origins of the highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b genotype B3.13, currently affecting various animal species and causing sporadic human infections. The first detection of HPAI H5N1 clade 2.3.4.4b in the Netherlands in 2020 raises concerns about earlier gain-of-function research. The proximal origins of HPAI H5N1 Clade 2.3.4.4b may be the USDA Southeast Poultry Research Laboratory (SEPRL) in Athens, Georgia and the Erasmus Medical Center in Rotterdam, the Netherlands. Genetic analysis indicates that genotype B3.13 emerged in 2024 and exhibits genetic links to genotype B1.2, which was identified to have originated in Georgia in January 2022 after the start of serial passage research with H5Nx clade 2.3.4.4 in mallard ducks at the USDA Southeast Poultry Research Laboratory (SEPRL) in Athens, Georgia in April 2021. Genotype B1.2 was found in a bottlenose dolphin (Tursiops truncatus) in March 2022 in Florida, indicating sudden new adaptations to different animal species. The NP gene of H5N1 clade 2.3.4.4b (genotype B3.13), which is causing outbreaks in cattle, was reported to have likely originated from an avian influenza A virus derived from mallard ducks. Significant mutations found in recent human cases, including PB2 E627K and PB2 M631L, also suggest links to serial passage experiments. However, further investigation is urgently needed to confirm these findings and to identify all H5N1 laboratory leaks that may have occurred with a focus on mallard ducks and other migratory waterfowl, which have the potential to infect a large number of poultry and livestock facilities around the world. A moratorium on gain-of-function research including serial passage of H5N1 is indicated to prevent a man-made influenza pandemic affecting animals and humans. preprints.org

@McCulloughFund - McCullough Foundation

JUST IN - Vermont Supreme Court rules that family cannot sue their child's school district after their 6-year-old was given a COVID-19 mRNA injection without their consent. "Clinic workers gave the child one dose of the Pfizer vaccine after the child was mistakenly given a name tag reading the name of another student ... the child 'verbally protested,' saying, 'Dad said no,'" the ruling reads." The Court ruled that state and school officials involved in the matter are protected under the Public Readiness and Emergency Preparedness (PREP) Act, which provides liability immunity. https://kmph.com/news/nation-world/school-cant-be-sued-after-child-received-covid-vax-against-parents-wishes-court-rules-vermont-windham-southeast-school-district-pfizer-vaccination-covid-19-pandemic-health-crisis-in-the-classroom #MFJustice

School can't be sued after child received COVID vax against parents' wishes, court rules The Vermont Supreme Court ruled Friday a family cannot sue their child's school district after their child was given a COVID-19 vaccine without their consent. kmph.com

@McCulloughFund - McCullough Foundation

BREAKING - In a major win against censorship, the landmark study that was unethically retracted after hundreds of thousands of views and called for global moratorium on COVID-19 mRNA injections has been re-published. "Rigorous re-analyses of trial data and post-marketing surveillance studies indicate a substantial degree of modmRNA-related harms than was initially reported. Confidential Pfizer documents had revealed 1.6 million adverse events by August 2022. A third were serious injuries to cardiovascular, neurological, thrombotic, immunological, and reproductive systems, along with an alarming increase in cancers." "Well-designed studies have shown that repeated modmRNA injections cause immune dysfunction, thereby potentially contributing to heightened susceptibility to SARS-CoV-2 infections and increased risks of COVID-19." Re-published study: https://ijvtpr.com/index.php/IJVTPR/article/view/101 Retracted (censored) study: https://www.cureus.com/articles/203052-covid-19-mrna-vaccines-lessons-learned-from-the-registrational-trials-and-global-vaccination-campaign#!/ #MFScholar

COVID-19 Modified mRNA “Vaccines” Part 1: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex | International Journal of Vaccine Theory, Practice, and Research ijvtpr.com

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign Our understanding of COVID-19 vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts. Published reports from the original randomized phase 3 trials concluded that the COVID-19 mRNA vaccines could greatly reduce COVID-19 symptoms. In the interim, problems with the methods, execution, and reporting of these pivotal trials have emerged. Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with previously established scientific standards. Among the other major topics addressed in this narrative review are the published analyses of serious harms to humans, quality control issues and process-related impurities, mechanisms underlying adverse events (AEs), the immunologic basis for vaccine inefficacy, and concerning mortality trends based on the registrational trial data. The risk-benefit imbalance substantiated by the evidence to date contraindicates further booster injections and suggests that, at a minimum, the mRNA injections should be removed from the childhood immunization program until proper safety and toxicological studies are conducted. Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits. Given the extensive, well-documented SAEs and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered. cureus.com

@McCulloughFund - McCullough Foundation

We have developed the first scientifically-backed proposal to deactivate COVID-19 mRNA injections in the human body. Government agencies and large research organizations have failed to produce any advances in treating COVID-19 injection injury syndromes, which are likely affecting millions of individuals. We explore the potential of small interfering RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs) as promising solutions to target, inactivate, and degrade residual and persistent vaccine mRNA, thereby potentially preventing uncontrolled Spike protein production and reducing toxicity. https://osf.io/preprints/osf/qxbgu #MFScholar

Strategic Deactivation of mRNA COVID-19 Vaccines: New Applications for RIBOTACs and siRNA Therapy The rapid development and authorization of mRNA vaccines by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) in 2020 marked a significant milestone in human mRNA product application, overcoming previous obstacles such as mRNA instability and immunogenicity. This paper reviews the strategic modifications incorporated into these vaccines to enhance mRNA stability and translation efficiency, such as the inclusion of nucleoside modifications and optimized mRNA design elements including the 5’ cap and poly(A) tail. We highlight emerging concerns regarding the wide systemic biodistribution of these mRNA vaccines leading to prolonged inflammatory responses and other safety concerns. The regulatory framework guiding the biodistribution studies is pivotal in assessing the safety profiles of new mRNA formulations in use today. The stability of mRNA vaccines, their pervasive distribution, and the longevity of the encapsulated mRNA along with unlimited production of the damaging and potentially lethal Spike (S) protein call for strategies to mitigate potential adverse effects. Here, we explore the potential of small interfering RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs) as promising solutions to target, inactivate, and degrade residual and persistent vaccine mRNA, thereby potentially preventing uncontrolled Spike protein production and reducing toxicity. The targeted nature of siRNA and RIBOTACs allows for precise intervention, offering a path to prevent and mitigate adverse events of mRNA-based therapies. This review calls for further research into siRNA and RIBOTAC applications as antidotes and detoxication products for mRNA vaccine technology. osf.io

@McCulloughFund - McCullough Foundation

JUST IN - Dr. Francis Boyle, the Harvard educated law professor that drafted the Biological Weapons and Antiterrorism Act of 1989, Provides Affidavit that COVID 19 mRNA injections are Biological Weapons and Weapons of Mass Destruction Dr. Boyle stated that the COVID-19 injections violate Biological Weapons 18 USC § 175 and Weapons and Firearms § 790.166 Fla. Stat. (2023). This affidavit was presented in a Florida case involving an Emergency Petition for a Writ of Mandamus, aiming to convince Governor DeSantis to ban the distribution of these injections in Florida. Additionally, it seeks to compel Attorney General Ashley Moody to confiscate the vials. #MFPolicy @PhdSansone